Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
32.57
+0.22 (0.68%)
Nov 6, 2025, 4:00 PM EST - Market closed
Korro Bio Stock Forecast
Stock Price Forecast
The 8 analysts that cover Korro Bio stock have a consensus rating of "Strong Buy" and an average price target of $96.25, which forecasts a 195.52% increase in the stock price over the next year. The lowest target is $25 and the highest is $147.
Price Target: $96.25 (+195.52%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Korro Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 5 | 5 | 6 |
| Buy | 5 | 5 | 4 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Clear Street | Clear Street | Strong Buy Initiates $93 | Strong Buy | Initiates | $93 | +185.54% | Oct 31, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | -23.24% | Aug 13, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $153 → $147 | Strong Buy | Maintains | $153 → $147 | +351.34% | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $90 | Strong Buy | Maintains | $100 → $90 | +176.33% | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +207.03% | Jul 24, 2025 |
Financial Forecast
Revenue This Year
4.93M
from 2.27M
Increased by 116.91%
Revenue Next Year
2.02M
from 4.93M
Decreased by -59.05%
EPS This Year
-10.35
from -9.37
EPS Next Year
-10.19
from -10.35
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.4M | 6.3M | |||
| Avg | 4.9M | 2.0M | |||
| Low | 3.9M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 224.1% | 27.9% | |||
| Avg | 116.9% | -59.1% | |||
| Low | 72.6% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -9.64 | -6.43 | |||
| Avg | -10.35 | -10.19 | |||
| Low | -10.99 | -17.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.